about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
27.40
1.48
(5.71%)
173.0K
XNAS Volume
XNAS 27 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..